The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Open accessAbstract
Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated, is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy. Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“modeling studies performed on the mutational data have estimated that the timeline of multistep progression to invasive neoplasia in the pancreas likely spans multiple years and provides a theoretically wide window of opportunity for early detection27.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [27]
In the citing paper
“Pancreatic tumours are highly heterogeneous, both within and between individuals.66,67”
From Early detection of pancreatic cancer (2020) · cites this paper as [67]
In the citing paper
“It is now appreciated that most clinically relevant solid tumors are highly heterogeneous at the phenotypic, physiologic, and genomic levels (13–15) and that they continue to evolve over time.”
From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Self-citationCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Isaacson, P. G., Doǧan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,913
Comparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Tibor Antal, A., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 827
Self-citationAdvanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Self-citationMaitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,006
Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients
Velasco, C. R., Li, J., Luttgen, M. S., Kolatkar, A. R., Kendall, J., Flores, E. I., Topp, Z. Z., Samlowski, W. E., McClay, E. F., Bethel, K. J., et al. (2015) · Physical Biology · doi:10.1088/1478-3975/12/1/016008 · Cited by 48
Controversies in the oncosurgical management of liver limited stage IV colorectal cancer
Jones, R. P., Stättner, S., Sutton, P. A., Dunne, D. F. J., McWhirter, D., Fenwick, S. W., Malik, H. M. A., & Poston, G. J. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2014.02.002 · Cited by 48
Exosomes: Potential for Early Detection in Pancreatic Cancer
Lu, L., & Risch, H. A. (2016) · Future Oncology · doi:10.2217/fon-2015-0005 · Cited by 49
Guo, J., Xie, K., & Zheng, S. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14995 · Cited by 47
Sensing of Alzheimer’s Disease and Multiple Sclerosis Using Nano-Bio Interfaces
Hajipour, M. J., Ghasemi, F., Aghaverdi, H., Raoufi, M., Linne, U., Atyabi, F., Nabipour, I., Azhdarzadeh, M., Derakhshankhah, H., Lotfabadi, A., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160206 · Cited by 47
Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases
Roato, I., & Ferracini, R. (2018) · Cancers · doi:10.3390/cancers10020056 · Cited by 49
Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
Llop, E., Guerrero, P. E., Duran, A., Barrabés, S., Massaguer, A., Ferri, M. J., Albiol-Quer, M., Llorens, R., & Peracaula, R. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i24.2537 · Cited by 47
Prolactin promotes fibrosis and pancreatic cancer progression
Tandon, M., Coudriet, G. M., Criscimanna, A., Socorro, M., Eliliwi, M., Singhi, A., Cruz-Monserrate, Z., Bailey, P., Lotze, M., Zeh, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3064 · Cited by 43
Delineating the evolutionary dynamics of cancer from theory to reality
Božić, I., & Wu, C. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0079-6 · Cited by 46
Lu, Z., Long, Y., Wang, Y., Wang, X., Xia, C., Li, M., Zhang, Z., & He, Q. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.05.014 · Cited by 46
Zhou, B., Irwanto, A. K., Guo, Y., Bei, J., Wu, Q., Chen, G., Zhang, T.-P., Lei, J.-J., Feng, Q.-S., Chen, L.-Z., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20839 · Cited by 46
Stem cells as the root of pancreatic ductal adenocarcinoma
Balic, A., Dorado, J., Alonso-Gómez, M., & Heeschen, C. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.11.007 · Cited by 49
Zebrafish as a model to assess cancer heterogeneity, progression and relapse
Blackburn, J. S., & Langenau, D. M. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.015842 · Cited by 52
DNA Sequencing of Cancer: What Have We Learned?
Chmielecki, J., & Meyerson, M. M. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-060712-200152 · Cited by 48
Goel, G., & Sun, W. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0141-5 · Cited by 46
Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies
Zhang, Y., Wan, Y., Sun, Y., Li, J., & Zhu, R. (2015) · Scientific Reports · doi:10.1038/srep15460 · Cited by 46
Corvigno, S., Wisman, G. B. A., Mezheyeuski, A., van der Zee, A. G. J., Nijman, H. W., Åvall-Lundqvist, E. H., Östman, A., & Dahlstrand, H. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7613 · Cited by 48
Metabolomics in pancreatic cancer biomarkers research
Tumas, J., Kvederavičiūtė, K., Petrulionis, M., Kurlinkus, B., Rimkus, A., Sakalauskaitė, G., Cicenas, J., & Šileikis, A. (2016) · Medical Oncology · doi:10.1007/s12032-016-0853-6 · Cited by 46
Diabetes and Pancreatic Cancer: Both Cause and Effect
Risch, H. A. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy093 · Cited by 45
Long, N. P., Jung, K. H., Anh, N. H., YAN, H. H., Nghi, T. D., Park, S., Yoon, S. J., Min, J. E., Kim, H. M., Lim, J. H., et al. (2019) · Cancers · doi:10.3390/cancers11020155 · Cited by 45
Yoshizawa, N., Sugimoto, K., Tameda, M., Inagaki, Y., Ikejiri, M., Inoue, H., Usui, M., Ito, M., & Takei, Y. (2020) · Oncology Letters · doi:10.3892/ol.2020.11357 · Cited by 46
de Castro, J. V., Gonçalves, C. S., Hormigo, A., & Costa, B. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155278 · Cited by 47
SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization
Dai, C., Rennhack, J. P., Arnoff, T. E., Thaker, M., Younger, S. T., Doench, J. G., Huang, A. Y., Yang, A., Aguirre, A. J., Wang, B. L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109443 · Cited by 45
Imodoye, S. O., Adedokun, K. A., & Bello, I. O. (2024) · Histochemistry and Cell Biology · doi:10.1007/s00418-023-02258-6 · Cited by 47
Matsuda, Y., Yoshimura, H., Ueda, J., Naito, Z., Korc, M., & Ishiwata, T. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.014 · Cited by 45
Predictive Modeling of In Vivo Response to Gemcitabine in Pancreatic Cancer
Lee, J. J., Huang, J. S., England, C. G., McNally, L. R., & Frieboes, H. B. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003231 · Cited by 44
Jesus‐Acosta, A. D., Oliver, G. R., Blackford, A. L., Kinsman, K., Flores, E. I., Wilfong, L. S., Zheng, L., Donehower, R. C., Cosgrove, D., Laheru, D. A., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1704-y · Cited by 45
Cancer heterogeneity: origins and implications for genetic association studies
Urbach, D., Lupien, M., Karagas, M. R., & Moore, J. H. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.07.001 · Cited by 44
MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer
Gayral, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11199 · Cited by 45
Jürgensmeier, J. M., Eder, J. P., & Herbst, R. S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0753 · Cited by 46
Metastatic mechanisms in follicular cell-derived thyroid cancer
Phay, J. E., & Ringel, M. D. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0187 · Cited by 45
CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells
Maeda, K., Ding, Q., Yoshimitsu, M., Kuwahata, T., Miyazaki, Y., Tsukasa, K., Hayashi, T., Shinchi, H., Natsugoe, S., & Takao, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071025 · Cited by 45
Pancreatic cancer stroma: controversies and current insights
Ansari, D., Carvajo, M., Bauden, M. P., & Andersson, R. E. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1293726 · Cited by 47
Endoscopic ultrasound findings and pathological features of pancreatic carcinoma in situ
Izumi, Y., Hanada, K., Okazaki, A., Minami, T., Hirano, N., Ikemoto, J., Kanemitsu, K., Nakadoi, K., Shishido, T., Katamura, Y., et al. (2019) · Endoscopy International Open · doi:10.1055/a-0839-4312 · Cited by 37
Yang, L., Li, N., Xue, Z., Liu, L.-R., Li, J., Huang, X., Xie, X., Zou, Y., Tang, H., & Xie, X. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-019-0485-4 · Cited by 45
Moutinho-Ribeiro, P., Costa-Moreira, P., Adem, B., Batista, I., Almeida, M., Barroca, H., Lopes, J., Carneiro, F., Melo, S., & Macedo, G. (2020) · Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · doi:10.1016/j.pan.2020.01.015 · Cited by 6
Liu, X., Wang, W., Liu, X., Zhang, Z., Yu, L., Li, R., Guo, D., Cai, W., Quan, X., Wu, H., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.670 · Cited by 45
Božić, I., & Nowak, M. A. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042716-094839 · Cited by 42
Self-citationLiffers, S., Godfrey, L., Frohn, L., Häberle, L., Yavas, A., Vesce, R., Goering, W., Opitz, F. V., Stoecklein, N. H., Knoefel, W. T., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326550 · Cited by 49
Court, C. M., Ankeny, J. S., Hou, S., Tseng, H., & Tomlinson, J. S. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1091311 · Cited by 44
van Erning, F. N., Crolla, R. M. P. H., Rutten, H. J. T., Beerepoot, L. V., van Krieken, J. H., & Lemmens, V. E. P. P. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.10.011 · Cited by 44
Adapting Clinical Paradigms to the Challenges of Cancer Clonal Evolution
Murugaesu, N., Chew, S. K., & Swanton, C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.026 · Cited by 42
Use of incretin agents and risk of pancreatic cancer: a population‐based cohort study
Knapen, L. M., Dalem, J. D. R.-V., Keulemans, Y. C. A., van Erp, N. P., Bazelier, M. T., Bruin, M. L. D., Leufkens, H. G. M., Croes, S., Neef, C., de Vries, F., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12605 · Cited by 45
Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
Corbo, V., Tortora, G., & Scarpa, A. (2012) · Current Drug Targets · doi:10.2174/138945012800564103 · Cited by 44
Gliomas Genomics and Epigenomics: Arriving at the Start and Knowing It for the First Time
Filbin, M. G., & Suvà, M. L. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044208 · Cited by 46
Tu, M., Pan, Y.-Z., Qiu, J.-X., Kim, E. J.-H., & Yu, A. (2016) · Oncotarget · doi:10.18632/oncotarget.9999 · Cited by 44
Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts
Ball, C. R., Oppel, F., Ehrenberg, K. R., Dubash, T. D., Dieter, S. M., Hoffmann, C. M., Abel, U. R., Herbst, F., Koch, M., Werner, J., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607354 · Cited by 43
Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments
Muraro, M. G., Muenst, S. E., Mele, V., Quagliata, L., Iezzi, G., Tzankov, A., Weber, W. P., Spagnoli, G. C., & Soysal, S. D. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1331798 · Cited by 44
Statin use and pancreatic cancer risk in two prospective cohort studies
Hamada, T., Khalaf, N. I., Yuan, C., Babić, A., Morales‐Oyarvide, V., Qian, Z. R., Nowak, J. A., Ng, K., Kraft, P. L., Rubinson, D. A., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1430-x · Cited by 45
Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell
Jiang, H., Gao, H., Kong, J., Song, B., Wang, P., Shi, B., Wang, H., & Li, Z. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0044 · Cited by 44
Follia, L., Ferrero, G., Mandili, G., Beccuti, M., Giordano, D., Spadi, R., Satolli, M. A., Evangelista, A., Katayama, H., Hong, W., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00115 · Cited by 44
Li, C., Wang, J., Lu, X., Ge, H., Jin, X., Guan, Q., Su, Y., Pan, R., Li, P., Cai, W., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120071 · Cited by 44
KDM6A regulates cell plasticity and pancreatic cancer progression by noncanonical activin pathway
Yi, Z., Wei, S., Jin, L., Jeyarajan, S., Yang, J., Gu, Y., Kim, H. S., Schechter, S., Lu, S., Paulsen, M. T., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.09.014 · Cited by 41
Biomarkers for early diagnosis of pancreatic cancer
Jenkinson, C., Earl, J., Ghaneh, P., Halloran, C., Carrato, A., Greenhalf, W., Neoptolemos, J., & Costello, E. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.965145 · Cited by 42
Applying next-generation sequencing to pancreatic cancer treatment
Mardis, E. R. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.126 · Cited by 43
Remodeling of the Methylation Landscape in Breast Cancer Metastasis
Reyngold, M., Turcan, Ş., Giri, D. D., Kannan, K. S., Walsh, L. A., Viale, A. J., Drobnjak, M., Vahdat, L. T., Lee, W., & Chan, T. A.-T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103896 · Cited by 43
He, H., Yang, D., Liang, M., Yang, F., Yao, L., Hao, S., Li, J., Jiang, Y., Jin, C., & Fu, D. (2013) · Oncology Reports · doi:10.3892/or.2013.2516 · Cited by 43
Biopsy for liver cancer: How to balance research needs with evidence‐based clinical practice
Sherman, M., & Bruix, J. (2014) · Hepatology · doi:10.1002/hep.27563 · Cited by 43
Genomic Sequencing for Cancer Diagnosis and Therapy
Wang, L., & Wheeler, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-120811-171056 · Cited by 44
Markers of Pancreatic Cancer: Working Toward Early Detection
Goggins, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3074 · Cited by 43
Cellular and molecular aspects of pancreatic cancer
Gharibi, A., Adamian, Y., & Kelber, J. A. (2016) · Acta Histochemica · doi:10.1016/j.acthis.2016.01.009 · Cited by 43
Modeling Tumor Clonal Evolution for Drug Combinations Design
Zhao, B., Hemann, M. T., & Lauffenburger, D. A. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.02.001 · Cited by 42
Metabolic Signaling to Epigenetic Alterations in Cancer
Kim, J., & Yeom, Y. I. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.185 · Cited by 45
Sajic, T., Liu, Y., Arvaniti, E., Šurinová, S., Williams, E. G., Schiess, R., Hüttenhain, R., Sethi, A., Pan, S., Brentnall, T. A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.114 · Cited by 43
Ma, B., Wells, A. H., & Clark, A. M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.021 · Cited by 44
Paracrine and cell autonomous signalling in pancreatic cancer progression and metastasis
Thomas, S. K., Lee, J., & Beatty, G. L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102662 · Cited by 46
T-Cell Immunity in Pancreatic Cancer
Ajina, R., & Weiner, L. M. (2020) · Pancreas · doi:10.1097/mpa.0000000000001621 · Cited by 46
Sagami, R., Yamao, K., Nakahodo, J., Minami, R., Tsurusaki, M., Murakami, K., & Amano, Y. (2021) · Cancers · doi:10.3390/cancers13050945 · Cited by 45
Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
Brezgyte, G., Shah, V. M., Jach, D., & Crnogorac‐Jurcevic, T. (2021) · Cancers · doi:10.3390/cancers13112722 · Cited by 46
Zhao, R., Ren, S., Li, C., Guo, K., Lu, Z., Tian, L., He, J., Zhang, K., Cao, Y., Liu, S., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5296 · Cited by 42
Fu, Y., Zhu, X., Ren, L., Wan, J., & Wang, H. (2024) · ACS Nano · doi:10.1021/acsnano.3c08425 · Cited by 42
Hedgehog Signaling and Pancreatic Tumor Development
Lauth, M., & Toftgård, R. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00001-3 · Cited by 43
A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells
Ischenko, I., Petrenko, O., & Hayman, M. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4538 · Cited by 42
Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas
Ouyang, L., Lee, J., Park, C.-K., Mao, M., Shi, Y., Gong, Z., Zheng, H., Li, Y., Zhao, Y., Wang, G., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-2 · Cited by 42
Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer
Crnogorac‐Jurcevic, T., Chelala, C., Barry, S., Harada, T., Bhakta, V., Lattimore, S., Jurčević, S., Bronner, M. P., Lemoine, N. R., & Brentnall, T. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054830 · Cited by 43
Hypermutable DNA chronicles the evolution of human colon cancer
Naxerova, K., Brachtel, E. F., Salk, J. J., Seese, A. M., Power, K. A., Abbasi, B., Snuderl, M., Chiang, S., Kasif, S., & Jain, R. K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400179111 · Cited by 40
Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications
de Bruin, E. C., Taylor, T., & Swanton, C. (2013) · Genome Medicine · doi:10.1186/gm505 · Cited by 44
Leichtle, A. B., Ceglarek, U., Weinert, P., Nakas, C. T., Nuoffer, J., Kase, J., Conrad, T., Witzigmann, H., Thiery, J., & Fiedler, M. (2012) · Metabolomics · doi:10.1007/s11306-012-0476-7 · Cited by 42
Inherent variability of cancer-specific aneuploidy generates metastases
Bloomfield, M., & DUESBERG, P. H. (2016) · Molecular Cytogenetics · doi:10.1186/s13039-016-0297-x · Cited by 42
Oligometastatic Disease in Pancreatic Cancer - How to Proceed
Renz, B. W., Boeck, S. H., Roeder, F., Trumm, C. G., Heinemann, V., & Werner, J. (2017) · Visceral Medicine · doi:10.1159/000455027 · Cited by 42
Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro, P., Macedo, G., & Melo, S. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00779 · Cited by 43
Chemotherapy and Tumor Evolution Shape Pancreatic Cancer Recurrence after Resection
Bednar, F., & di Magliano, M. P. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0359 · Cited by 42
Jentzsch, V., Davis, J., & Djamgoz, M. B. A. (2020) · Cancers · doi:10.3390/cancers12113096 · Cited by 45
Breast Cancer Heterogeneity in Primary and Metastatic Disease
Kalinowski, L., Saunus, J. M., Reed, A. E. M., & Lakhani, S. R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-20301-6_6 · Cited by 47
Nakahodo, J., Kikuyama, M., Fukumura, Y., Horiguchi, S.-I., Chiba, K., Tabata, H., Suzuki, M., & Kamisawa, T. (2022) · Pancreatology · doi:10.1016/j.pan.2022.10.003 · Cited by 41
Early detection of pancreatic cancer.
Kim, V. M., & Ahuja, N. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2015.07.03 · Cited by 44
Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis
Qiu, W., & Su, G. H. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9408-2 · Cited by 45
Interphase microtubules: chief casualties in the war on cancer?
Ogden, A., Rida, P. C. G., Reid, M. D., & Aneja, R. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.022 · Cited by 41
Pancreatic cancer stem cells – insights and perspectives
Hermann, P. C., Mueller, M.-T., & Heeschen, C. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903246362 · Cited by 41
Protein deep sequencing applied to biobank samples from patients with pancreatic cancer
Ansari, D., Andersson, R. E., Bauden, M. P., Andersson, B., Connolly, J. B., Welinder, C., Sasor, A., & Marko‐Varga, G. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1817-x · Cited by 41
Hamam, D., Abdouh, M., Gao, Z., Arena, V., Arena, M., & Arena, G. O. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0360-9 · Cited by 42
Omega-3 Fatty Acids Prevent Early Pancreatic Carcinogenesis via Repression of the AKT Pathway
Ding, Y., Mullapudi, B., Torres, C., Mascariñas, E., Mancinelli, G. E., Diaz, A. M., McKinney, R. D., Barron, M. R., Schultz, M., Heiferman, M. J., et al. (2018) · Nutrients · doi:10.3390/nu10091289 · Cited by 41
A primer on artificial intelligence in pancreatic imaging
Ahmed, T. M., Kawamoto, S., Hruban, R. H., Fishman, E. K., Soyer, P. A., & Chu, L. C. H. (2023) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2023.03.002 · Cited by 44
Self-citationMolecular markers in pancreatic cancer diagnosis
Herreros‐Villanueva, M., Gironella, M., Castells, A., & Bujanda, L. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.025 · Cited by 41
A biomimetic tumor model of heterogeneous invasion in pancreatic ductal adenocarcinoma
Bradney, M. J., Venis, S. M., Yang, Y., Konieczny, S. F., & Han, B. (2020) · Small · doi:10.1002/smll.201905500 · Cited by 38
State-dependent evolutionary models reveal modes of solid tumour growth
Lewinsohn, M., Bedford, T., Müller, N. F., & Feder, A. F. (2023) · Nature Ecology & Evolution · doi:10.1038/s41559-023-02000-4 · Cited by 41
Reporting Tumor Molecular Heterogeneity in Histopathological Diagnosis
Mafficini, A., Amato, E., Fassan, M., Simbolo, M., Antonello, D., Vicentini, C., Scardoni, M., Bersani, S., Gottardi, M., Rusev, B. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104979 · Cited by 40
Tamura, K., Ohtsuka, T., Date, K., Fujimoto, T., Matsunaga, T., Kimura, H., Watanabe, Y., Miyazaki, T., Ohuchida, K., Takahata, S., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000563 · Cited by 42
Wong, M. H., Xue, A., Baxter, R. C., Pavlakis, N., & Smith, R. C. (2016) · Neoplasia · doi:10.1016/j.neo.2016.06.001 · Cited by 40
Lapin, M., Tjensvoll, K., Oltedal, S., Javle, M. M., Smaaland, R., Gilje, B., & Nordgård, O. (2017) · BMC Cancer · doi:10.1186/s12885-017-3385-3 · Cited by 40
Metadata
- Authors
- Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- ORCID
- Venue
- Nature
- Published
- 2010-10
- Volume
- 467
- Issue
- 7319
- Pages
- 1114-1117
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3148940
- OpenAlex
- W2169895148
- Cited by
- 2,502
- References
- 24
- Citations by year
- 2026: 73 · 2025: 84 · 2024: 76 · 2023: 105 · 2022: 122 · 2021: 165 · 2020: 157 · 2019: 147 · 2018: 176 · 2017: 218 · 2016: 208 · 2015: 237 · 2014: 224 · 2013: 182 · 2012: 197
- FWCI
- 50.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01ca121113-15)
- U.S. Public Health Service (A62924)
- National Cancer Institute (R01CA140599, CA 57345, R01-CA121113, CA-121113, CA43460, K08CA106610, R37CA043460, R01CA057345, CA106610, P50CA062924, R37CA057345)
- National Institute of General Medical Sciences (R01GM078986, GM078986)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic cancer, distant metastasis, clonal evolution, tumor subclones, chromosomal rearrangements, genomic instability, early detection, tumor heterogeneity, therapeutic target
- MeSH terms
- Adenocarcinoma, Autopsy, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Models, Biological, Mutation, Neoplasm Metastasis, Pancreas, Pancreatic Neoplasms, Peritoneal Neoplasms, Time Factors, Disease Progression, Cell Lineage, Evolution, Molecular, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
